share_log

科华生物(002022.SZ):在宠物市场实现零的突破是公司2023年经营计划之一

Kehua Biotech (002022.SZ): Achieving zero breakthrough in the pet market is one of the company's 2023 business plans

Gelonghui Finance ·  06/07/2023 09:01

Gelonghui June 7th 丨Kehua Biotech (002022.SZ) was surveyed by the agency. During the Q&A session, “Has the company laid out the pet market?”

The company replied that the rapid development of the Chinese pet market has led to a rise in demand for pet diagnosis and treatment. The company is developing biochemicals, coagulation, luminescent POCT and other products, and achieving a zero breakthrough in the pet market is one of the company's 2023 business plans.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment